nuclear factor-B; transcription factor; cytokine; pulmonary inflammation THE LUNG IS AN IMPORTANT TARGET ORGAN for systemic inflammatory mediators released after major trauma (6, 39, 44) and severe infection (113, 118) . Acute respiratory distress syndrome (ARDS), clinically manifested as inflammatory lung injury of very rapid onset, is characterized by intractable respiratory dysfunction. This syndrome is associated with hypoxemia, reduced lung compliance, and diffuse infiltrations (13) . Neutrophils sequestered in the lung play a central role in the pathogenesis of ARDS (50) . Lung neutrophil accumulation seen in ARDS is thought to occur as a result of a cascade of cellular events initiated by either infectious or noninfectious inflammatory stimuli. Local activation of resident cells in the lung interstitium and alveolus, primarily macrophages, leads to elaboration of several proinflammatory cytokines such as tumor necrosis factor (TNF)-␣ and interleukin (IL)-1␤ and chemokines including IL-8 and macrophage inflammatory protein (MIP)-2␣ (35, 37, 47, 87) . These mediators act in concert to promote neutrophil sequestration by activating endothelial cell adhesion molecule expression and to induce migration of neutrophils into the interstitium and alveolar space where they propagate inflammation and injury through the release of reactive oxygen species (ROS) and proteolytic enzymes (155) . A counterinflammatory response in the lungs is also initiated with the release of anti-inflammatory cytokines such as IL-10, IL-4, IL-13, IL-1 receptor antagonist (IL-1RA), and transforming growth factor (TGF)-␤ (36, 47, 109) . Elevated levels of proinflammatory mediators combined with decreased expression of anti-inflammatory molecules correlate with the magnitude of lung injury and its outcome (108) . The imbalance between proinflammatory and anti-inflammatory mechanisms is a critical component of lung inflammation.
The signals that lead to increased gene expression and biosynthesis of proinflammatory mediators by airspace inflammatory and epithelial cells are thus of considerable interest. An understanding of the expression of genes, in particular the transcriptional apparatus usually located in the upstream region of the gene promoter, is required to explain the regulation of ex-pression of proinflammatory genes. Nuclear factor (NF)-B is one such critical transcription factor required for maximal expression of many cytokines involved in the pathogenesis of ARDS. NF-B, first identified by Sen and Baltimore (124) , functions to enhance the transcription of a variety of genes, including cytokines and growth factors, adhesion molecules, immunoreceptors, and acute-phase proteins (a list of genes containing NF-B sites in their promoters is shown in Table 1 ). Under resting condition, NF-B functions in regulating the expression of genes involved in normal immunologic responses such as the generation of antibody light chains and other immunoregulatory molecules (124, 152) . NF-B activation is necessary for an intact host defense response, whereas excessive activation of NF-B results in overly exuberant inflammatory injury of lungs and other organs (17, 18, 40) .
In this review, we focus on the recent progress in our understanding of the role of NF-B and interactions between NF-B and other transcription factors in the pathogenesis of acute lung injury.
MOLECULAR BIOLOGY OF NF-B
The NF-B family of transcription factors. NF-B belongs to the Rel family of proteins that are ubiquitous transcription factors sharing a common structural motif for DNA binding and dimerization (10) . Although, for the sake of simplicity, NF-B is often referred to as a single entity, it is, in reality, a complex mixture of homodimers and heterodimers, all with distinct characteristics and biological properties. The cloning of NF-B family members has revealed five distinct subunits homologous to the protooncogene cRel and the Drosophila melanogaster morphogen dorsal: NF-B1 (p50/105), NF-B2 (p52/100), Rel A (p65), Rel B, and c-Rel itself (10, 134) . These subunits are all highly related over an ϳ300-residue amino-terminal DNA binding and dimerization domain termed the Rel homology domain.
Activation of NF-B. NF-B is normally sequestered in the cytoplasm through its association with an inhibitor protein called inhibitory B (IB), which masks the nuclear translocation signal and thus prevents NF-B from entering the nucleus. NF-B activation represents the terminal step in a signal transduction pathway leading from the cell surface to the nucleus. On exposure of the cell to activation signals such as the binding of lipopolysaccharide (LPS), TNF-␣, or IL-1␤ to cell surface receptors, the IB protein is phosphorylated on serine-32 and serine-36, ubiquinated, and degraded in proteasomes. After being freed from association with IB, the NF-B complex moves to the nucleus where it binds to specific sequences in the promoter/enhancer regions of genes.
A wide variety of extracellular stimuli can trigger the activation of NF-B, and the list of NF-B inducers is rapidly expanding. Well-characterized inducers include proinflammatory cytokines (11), bacterial and viral products (8, 17, 160) , and ROS. Many of the agents that activate NF-B, such as TNF-␣, IL-1␤, and LPS, also increase the cellular production of ROS by mitochondria (115) and play significant roles in the pathophysiology of acute lung injury. ROS have been recognized as important inducers of gene expression via NF-B. Evidence for cellular oxidative signaling involvement in the activation of NF-B is based on four key observations: 1) antioxidants such as pyrrolidine dithiocarbamate and N-acetylcysteine (NAC) abolish LPS-induced activation of NF-B (73, 77, 78, 120, 161) , 2) in vitro administration of H 2 O 2 to cells stimulates activation of NF-B (92), 3) NAC blocks activation of NF-B in animal models of ARDS and improves lung function in patients with ARDS (16, 59, 140) , and 4) overexpression of antioxidant enzymes such as manganese superoxide dismutase or glutathione peroxidase abolishes NF-B activation induced by TNF-␣, LPS, phorbol esters, and H 2 O 2 (65, 81) . Recently, however, Bowie and O'Neill (21), after reviewing the evidence for the oxidative stress model, concluded that in most cases the role of oxidative stress in NF-B activation is at best facilitatory rather than causal. Furthermore, some studies show that redox activation of NF-B is likely dependent on the nature of the mediator and selectivity of the signaling pathways activated as well as on the specific cell type (reviewed on Ref. 57 ). Indeed, the molecular basis for this regulation of NF-B activation by ROS is poorly understood. It is clear, however, that NF-B induction is mainly dependent on phosphorylation and degradation of IB (4, 86, 125 TNF, tumor necrosis factor; IL, interleukin; MIP, macrophage inflammatory protein; MCP-1, monocyte chemoattractant protein-1; Gro, growth-regulated peptide; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular cell adhesion molecule-1; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IB-␣, inhibitory B-␣; NF-B, nuclear factor-B; IFN-␤, interferon-␤. recent study (55) provided evidence that there are also other optional NF-B activating pathways such as tyrosine phosphorylation of IB.
NF-B inhibitors and their regulation. The various forms of IB include IB-␣, IB-␤, IB-⑀, and Bcl-3 (10, 45, 153) . In addition, p105, which is the precursor of p50, and p100, which is the precursor of p52, can bind Rel A and thus function as NF-B inhibitors (31, 83, 97) . The COOH-terminal portions of p105 and p100 have been designated IB-␥ and IB-␦, respectively. These inhibitory units contain multiple copies of ankyrin repeat domains that allow interaction with NF-B in a configuration that masks the nuclear localization signal domains of NF-B, thereby preventing nuclear transport (7) . Signaling pathways leading to NF-B activation converge on phosphorylation, ubiquitination, and degradation of IBs (except Bcl-3), which unmask the nuclear localization signal leading to translocation of NF-B/Rel dimers into the nucleus (4, 86, 125) . IBs are also active in the nucleus. IB-␣ and IB-␤ interact with p50/p65 NF-B heterodimers in the nucleus as in the cytoplasm, inhibiting transcriptional activity of NF-B (4, 144) . In experiments examining NF-B activation in the lung, levels of IB-␣ in the nucleus as well as in the cytoplasm were elevated in a mixed population of intraparenchymal lung cells after hemorrhagic shock in association with NF-B nuclear translocation (94) . These findings suggest that 1) IB-␣ is upregulated by NF-B and 2) other IB proteins contribute to NF-B activation in the lung after blood loss.
Bcl-3 is an unusual IB protein in that it cannot only inhibit nuclear NF-B complexes but also bind to p50 and p52 dimers on DNA and form a complex with transactivating activity (19, 46) . The highest expression of Bcl-3 is found in lymph nodes and spleen, and as such, Bcl-3 has been shown to play a critical role in antigen-specific T cell immunity (9, 14, 20) . However, a recent study (46) showed that Bcl-3 levels are increased after hemorrhage in intraparenchymal lung cells, suggesting that such alterations in Bcl-3 can contribute to the observed increased expression of NF-B-dependent genes in the lungs.
IB phosphorylation requires IB kinase (IKK) activation (26, 154) . Two closely related IKKs have been identified and cloned (34, 91, 112, 154, 158) and are referred to as IKK-␣ and IKK-␤. IKK-␣ and IKK-␤ are 52% identical in their amino acids. Both kinases directly phosphorylate Ser 32 and Ser 36 of IB-␣, and overexpression of each wild-type kinase leads to NF-B activation (154) . The activities of IKK-␣ and IKK-␤ are stimulated by TNF-␣, IL-1␤, and LPS treatment (91, 101) . However, targeted deletion of the murine IKK-␣ and IKK-␤ revealed different functions of these kinases. Whereas mice lacking IKK-␤ had a defective response to inflammatory cytokines, mice lacking IKK-␣ displayed developmental defects (53, 71, 72) . IKK-␣ and IKK-␤ form a heterodimer that can interact directly with the upstream kinase NF-B-inducing kinase (NIK) (112) . These three kinases are considered to be present in the large 177-kDa IB kinase complex (26, 29) . The IKK-␥/NF-B essential modulator was cloned by genetic complementation of an HTLV-1 Taxtransformed rat fibroblast cell line (156) and by biochemical purification (90, 117) . IKK-␥ is essential for NF-B activation by LPS, TNF-␣, IL-1␤, or phorbol 12-myristate 13-acetate. Deletions of either the amino terminus or carboxy terminus of IKK-␥ blocked NF-B activation (90, 117) . IKK-␥ is composed of coiled-coil motifs including a leucine zipper (117) through which it presumably recruits upstream activators to the IKK complex. An amino-terminal ␣-helical region of IKK-␥ is responsible for interacting with a carboxy-terminal domain of IKK-␣ and IKK-␤. Overexpression of this IKK-␥-interacting domain could block association of IKK-␣,␤ with IKK-␥ and thereby inhibit cytokine-induced NF-B activation (85) .
Shimada et al. (133) reported a novel LPS-inducible IKK referred to as IKK-i. IKK-i shares 30% identity with IKK-␣ or IKK-␤. IKK-i is expressed mainly in immune cells and is induced in response to proinflammatory cytokines such as TNF-␣, IL-1␤, and IL-6 as well as to LPS. Another molecule, IKK-associated protein, was suggested to be a scaffold protein that binds to NIK and IKKs and assembles them into an active kinase complex (29) . Overexpression of IKK-associated protein inhibited TNF-␣-and IL-1␤-induced NF-B reporter activity (29) , indicating its role in regulating the activity of IB. Moreover, Pomerantz and Baltimore (111) have identified another novel kinase, TBK1, related to IKK-␣ or IKK-␤ and 48% identical to IKK-i, that associates with the TNF receptor-associated factor (TRAF)-binding protein TANK. TBK1 mediates NF-B activation by TRAF-2, TRAF-5, TRAF-6, and TANK. TBK1 forms a complex with TANK and TRAF-2 that functions upstream from the NIK-IKK complex, but TBK1 does not appear to be required for the activation of NF-B by TNF-␣, IL-1␤, or CD14. Thus TANK and TBK1 probably belong to a separate pathway induced by different stimuli.
Nakano et al. (96) showed that mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1 (MEKK1), which constitutes the c-Jun NH 2 -terminal kinase/stress-activated protein kinase pathway, also activates NF-B. The overexpression of MEKK1 preferentially stimulated the kinase activity of IKK-␤, which resulted in phosphorylation of IBs (96) . In contrast, overexpression of NIK comparably stimulates kinase activities of both IKK-␣ and IKK-␤, suggesting a qualitative difference between NIK-and MEKK1-mediated NF-B activation pathways (96) . The dominant negative mutant of MEKK1, on the other hand, partially blocks activation of IKK by TNF-␣ (98). Furthermore, MEKK1 appears to act in parallel to NIK, leading to synergistic activation of the IKK complex. The formation of the MEKK1-IKK complex versus the NIK-IKK complex may provide a molecular basis for the regulation of the IKK complex by various extracellular signals (98) . These results suggest that NIK and MEKK1 can independently activate the IKK complex, and the kinase activities of IKK-␣ and IKK-␤ are differentially regulated by two up-stream kinases, NIK and MEKK1, both of which are responsive to distinct stimuli. Another group, Zhao and Lee (159) , showed that MEKK2 and MEKK3 can activate in vivo IKK-␣ and IKK-␤, induce site-specific IB-␣ phosphorylation, and activate a NF-B reporter gene. In addition, dominant negative versions of either IKK-␣ or IKK-␤ abolished NF-B activation induced by MEKK2 or MEKK3, thereby providing evidence that these IKKs mediate the NF-B-inducing activities of these MEKKs. In contrast, other mitogen-activated protein kinase kinase kinases, including MEKK4, apoptosis signal-regulated kinase 1, and mixed lineage kinase 3, failed to induce activation of the NF-B pathway.
An alternative mechanism of NF-B activation through tyrosine phosphorylation but not through degradation of IB-␣ has also been reported (55) . Stimulation of Jurkat T cells with the protein tyrosine phosphatase inhibitor and T cell activator pervanadate led to NF-B activation (55) . Pervanadate induced IB-␣ phosphorylation, and NF-B activation required the expression of the T cell tyrosine kinase p56 ick . Tyrosine phosphorylation of IB-␣ represents a proteolysis-independent mechanism of NF-B activation that directly couples NF-B to cellular tyrosine kinase. By site-specific mutagenesis and deletion analysis, Singh et al. (135) identified Tyr 42 on IB-␣ as the phospho acceptor site. On investigating the mechanism by which pervanadate inhibits the degradation of IB-␣, they showed in an in vitro reconstitution system that tyrosine-phosphorylated IB-␣ was protected from degradation. This study demonstrated that inducible phosphorylation and degradation of IB-␣ are negatively regulated by phosphorylation at Tyr 42 , thereby preventing NF-B activation. The findings reveal an important interaction between these two pathways.
In the signaling of TNF␣-or IL-1␤-induced NF-B activation, the serine/threonine kinase Akt/protein kinase B has been identified as another important signaling component (38) . Akt kinase is normally activated via the phosphoinositide 3-OH-kinase signaling pathway. Ozes et al. (104) , working with epithelial cells, showed that TNF-␣ activated Akt and that inhibition of Akt blocked the TNF-␣-induced activation of NF-B, indicating that Akt associates with IKK-␣ and mediates its phosphorylation. Figure 1 provides a summary of the mechanisms of IB regulation outlined above.
BACTERIA-INDUCED NF-B ACTIVATION: ROLE OF TOLL-LIKE RECEPTORS
Infection with microbial pathogens and septicemia are major causes of acute lung injury. Major causative agents include gram-negative and/or gram-positive bacteria. Septic shock and acute lung injury follow a pattern in which one or more products of microbial pathogens such as the endotoxin of gram-negative bacteria, diverse membrane components of gram-positive bacteria, and nonmethylated CpG-rich sequences of bacterial DNA activate the innate immune system. This system represents the immediate host defense mechanism that involves the secretion of cytokines and other mediators with antimicrobial effects. It is well documented that phylogenetically conserved signaling mechanisms provide an immediate cellular reaction that utilizes NF-B at the center of its first line of defense (89) . The recognition of a pathogen is mediated by a set of germ line-encoded receptors referred to as pattern-recognition receptors, which directly recognize invariant molecular structures (pathogen-associated molecular patterns). These are shared by large groups of microorganisms (56, 88) . The three functional classes of pattern-recognition receptors are signaling receptors, endocytic receptors, and secreted proteins. Studies over the past few years have demonstrated that a family of signaling receptors, known as the Toll-like receptors (TLRs), plays a crucial role in Drosophila and mammalian host defense. In both organisms, TLRs activate intracellular signaling, notably via NF-B. At least nine TLRs have been identified in humans, but only three of them have been characterized as interacting with a ligand of bacterial origin (89, 116, 142) . TLR2 is a receptor for peptidoglycan and lipopeptide from gram-positive bacteria and zymosan from yeast. TLR4 recognizes LPS from gram-negative bacteria (reviewed in Ref. 102) . It was recently shown that TLR9 is a putative receptor for bacterially derived CpG DNA (51) . All members of the Toll family are membrane proteins that span the membrane once and share similar extracellular domains, which include 18-31 leucine-rich repeats and similar cytoplasmic domains of ϳ200 amino acids. Interestingly, the latter domain is also similar to the cytoplasmic domain of the IL-1 receptor [Toll/IL-1 receptor homologous region (TIR)]. The cytoplasmic domains of the Toll family define a subclass of TIR domains. The TIR domain of human TLR4, for example, is 32% identical to Drosophila Toll but less similar (20% identical) to the TIR domain of the IL-1 receptor.
Specific components of microbial cell walls are strong activators of innate immune responses. Human pathogen-associated molecular patterns such as LPS of gram-negative bacteria and peptidoglycan and lipoteichoic acid components of gram-positive bacteria trigger the production of IL-1␤, TNF-␣ (103, 122, 141, 157) , and IL-6 (74) as well as of cyclooxygenase metabolites (114) . Recent genetic and biochemical experiments have highlighted the critical role of TLRs in LPSinduced NF-B activation (27, 60, 100) . Importantly, the responsiveness of TLRs to LPS is dependent on LPS binding protein and CD14 (121, 139) . On binding of LPS to TLRs via CD14, a number of molecules are recruited to the receptor to mediate NF-B activation (Fig. 2) . First, the adaptor molecule myeloid differentiation factor 88 (MyD88) binds to the receptor and interacts through its death domain with the protein kinase IL-1 receptor-associated kinase (IRAK), which, in turn, recruits the adaptor TRAF-6 to the receptor complex (49) . The importance of MyD88 in LPS signaling was confirmed by analysis of MyD88-deficient mice, which are normally highly resistant to LPS-induced shock (62) . Evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) bridges TRAF-6 to MEKK1. This protein is specific for the Toll/IL-1 pathway and is a regulator of MEKK1 processing (64) . Expression of wild-type ECSIT accelerates the processing of MEKK1, whereas a dominant negative fragment of ECSIT blocks MEKK1 processing and activation of NF-B (64) . A recent study (3) indicated that stimulation of TLR2 by Staphylococcus aureus induces NF-B activation through the small GTPases Rac1 and Cdc42.
Resuscitated hemorrhagic shock is believed to promote the development of lung injury by priming the immune system for an exaggerated inflammatory response to a second, often trivial, stimulus, the so-called "two-hit hypothesis" (41, 95) . In recent studies, a rodent model of LPS-induced lung injury after resuscitated hemorrhagic shock was used to examine the regulation of TLR4 gene and protein expression in vivo and to evaluate the impact of its regulation on the development of inflammation (Fan J and Rotstein OD, unpublished data). The studies have demonstrated that intratracheal LPS alone induces a rapid reduction of TLR4 mRNA in the whole lung and recovered alveolar macrophages. This effect appeared to be due to a lowering of TLR4 mRNA stability by ϳ69%. In contrast, although shock and resuscitation alone have no effect on TLR4 mRNA levels, they markedly alter the response to LPS. Specifically, the antecedent shock prevented the LPS-induced reduction in TLR4 mRNA levels in whole lung tissue and alveolar macrophages. This reversal can be explained by the ability of prior resuscitated shock to prevent the destabilization of TLR4 mRNA by LPS as well as to augment LPSstimulated TLR4 gene transcription compared with LPS alone. Oxidant stress related to shock or resuscitation appears to contribute to the regulation of TLR4 mRNA. Supplementation of the resuscitation fluid with the antioxidant NAC reversed the ability of shock or resuscitation to preserve TLR4 mRNA levels after LPS. TLR4 protein levels in whole lung and surface expression on alveolar macrophages mirrored the changes seen in TLR4 mRNA. Furthermore, preservation of surface TLR4 receptors in LPS-treated alveolar macrophages recovered from shock or resuscitated animals correlated with enhanced NIK activity, NF-B nuclear translocation, and inflammatory cytokine gene transcription (Fan J and Rotstein OD, personal communication). These data suggest that Tlr4 expression is controlled both transcriptionally as well as posttranscriptionally through altered mRNA stability and that changes in the local cellular microenvironment profoundly influence the net effect of these processes and, ultimately, cell responsiveness.
ROLE OF NF-B IN THE LUNG INFLAMMATORY RESPONSE
Increasing evidence shows an important role for NF-B in the pathogenesis of acute lung inflammation. Ref. 17) . All of these factors play an important role in lung inflammatory injury (30) . These in vitro findings are supported by a study in humans with ARDS (123) showing enhanced NF-B activation in alveolar macrophages recovered by bronchoalveolar lavage. In addition, an in vivo study in animals (82) has shown an association between NF-B activation and the expression of cytokines, chemokines, and vascular adhesion molecules (82) . Recent studies in vivo demonstrated that lung NF-B activation is suppressed by antioxidants (16, (76) (77) (78) or anti-inflammatory cytokines (70) , resulting in decreased proinflammatory mediator expression and reduced inflammatory injury. Thus it appears that activation of NF-B is central to the development of pulmonary inflammation and acute lung injury.
In vitro studies have shown that NF-B regulates gene expression of cytokines (TNF-␣, IL-1␤), chemokines [MIP-2, cytokine-induced neutrophil chemoattractant (CINC)], and adhesion molecules [intercellular adhesion molecule (ICAM)-1, E-selectin] (see
Lung neutrophil activation and apoptosis. Acute lung injury is characterized by the accumulation of neutrophils in the lungs, accompanied by the development of interstitial edema and an intense inflammatory response. A study (2) has addressed the role of neutrophils as early immune effectors in hemorrhageor endotoxemia-induced lung injury. Mice were made neutropenic with cyclophosphamide or anti-neutrophil antibodies, and it was shown that endotoxemia-or hemorrhage-induced lung edema was significantly reduced in those animals (2) . Activation of NF-B after hemorrhage or endotoxemia was also diminished in the lungs of neutropenic mice compared with the lungs in nonneutropenic mice. These experiments show that neutrophils play a central role in initiating acute inflammatory responses and inducing tissue injury in lungs after hemorrhage or endotoxemia.
Proinflammatory cytokines such as IL-1␤, TNF-␣, and MIP-2 can be produced by resident pulmonary cell populations, including alveolar macrophages and vascular endothelium (63, 143) . Neutrophils that accumulate in the lungs after endotoxemia or hemorrhage also appear to be a significant intrapulmonary source of IL-1␤ and other immunoregulatory cytokines (107) . Shenker and Abraham (132) demonstrated that activated NF-B contributes to lung neutrophil accumulation and expression of IL-1␤, TNF-␣, and MIP-2 mRNAs in lung neutrophils from endotoxemic or hemorrhaged mice.
In addition to enhancing transcription of immunomodulatory genes, NF-B plays an important role in apoptosis, presumably by regulating the expression of genes important in regulating cell death (147) . In particular, increased NF-B activation results in decreased apoptosis and increased cell life spans. This effect of NF-B activation is a potential determinant of acute lung injury. An increased number of activated neutrophils that generate ROS and proinflammatory cytokines is present in the lungs of patients with ARDS, and these neutrophils have decreased rates of apoptosis (84, 106, 107) . In experimental models of acute lung injury secondary to hemorrhage or endotoxemia, NF-B was activated in the lungs and apoptosis was reduced in the neutrophil population (106) . Thus increased survival of proinflammatory neutrophils in the lungs of patients with ARDS secondary to NF-B activation may perpetuate the pulmonary inflammatory response. Inhibition of NF-B activation in patients with ARDS may not only reduce the expression of proinflammatory mediators but also speed the resolution of lung injury by decreasing the numbers of activated resident neutrophils.
Alveolar macrophages. Alveolar macrophages are strategically situated at the air-tissue interface in the alveoli and alveolar ducts and are therefore the first cells encountered by inhaled organisms and antigens in the lower respiratory tract. Alveolar macrophages not only act in their traditional role as phagocytes but also function as potent secretory cells. Alveolar macrophages, on appropriate simulation, can release a wide variety of biologically active products and thereby play an important role in regulating inflammatory reactions within the lung. Depletion of alveolar macrophages by intratracheal instillation of liposomes containing the compound dichloromethylene diphosphonate has been used to study alveolar macrophage functions in vivo (23, 30, 129) . It has been shown with this technique that depletion of alveolar macrophages reduces lung production of TNF-␣ and neutrophil recruitment in a model of LPS-induced lung inflammation (12, 48) . In a model of bacterial pneumonia (23) , depletion of alveolar macrophages by dichloromethylene diphosphonate-liposomes unexpectedly caused increased lung production of TNF-␣ and increased lung neutrophil recruitment. Although the nature of the stimulus may dictate the function of alveolar macrophages, it appears from the latter study that sources of TNF-␣ other than alveolar macrophages, under special circumstances, are important to the development of lung inflammatory injury.
The mechanism of NF-B activation during lung inflammatory injury is known to require TNF-␣ and IL-1␤, which operate as autocrine/paracrine stimulators of alveolar macrophages (69) . Alveolar macrophage activation is generally an initial event in the genesis of lung inflammatory reactions. In a rat model of injury induced by intrapulmonary deposition of IgG immune complexes, Lentsch et al. (70) showed that early activation of alveolar macrophages occurred in an NF-B-dependent manner. Furthermore, NF-B activation in alveolar macrophages in vivo occurred before NF-B activation in whole lung tissues, and depletion of alveolar macrophages attenuated NF-B activation in whole lung tissues and decreased the bronchoalveolar lavage fluid content of proinflammatory mediators. In addition, lung instillation of TNF-␣ in alveolar macrophage-depleted rats induced NF-B activation in whole lungs (68) . These results indicate that the products of activated alveolar macrophages such as TNF-␣ are essential in stimulating nuclear translocation of NF-B in other lung cell types.
Several other animal models have also been used to evaluate the role of NF-B in the production of inflammatory events in alveolar macrophages. Blackwell et al. (18) described a rat model of neutrophilic lung inflammation after intraperitoneal endotoxin injection. In this model, endotoxin injection is followed by activation of NF-B in alveolar macrophages and lung tissue (16, 18) . Activation of NF-B correlated with the expression of mRNA of CINC, a neutrophil chemotactic chemokine, and this was followed by an influx of neutrophils into the alveolar space (18, 41) . In addition, blocking endotoxin-induced NF-B activation in lung tissue resulted in decreased CINC mRNA expression and diminished neutrophilic lung inflammation (16). Fan et al. (40) used a "two-hit" model of resuscitated hemorrhagic shock followed by intratracheal LPS in the rodent to evaluate the cellular mechanisms underlying enhanced fibrin deposition in the alveolar space. The results demonstrated that shock alone has little effect on the procoagulant milieu of the lung, whereas it primed the lung for increased NF-B activity and macrophage tissue factor-dependent procoagulant activity as well as enhanced plasminogen activator inhibitor in response to a small dose of LPS. These findings further support the concept that regulating NF-B activation in alveolar macrophages can significantly inhibit inflammatory events. Although the importance of NF-B in cytokine transcription has been established in animal models, only a few published studies have demonstrated a role for NF-B in human alveolar macrophages. Schwartz et al. (123) reported that NF-B in alveolar macrophages from patients with ARDS is activated to a significantly higher degree than in alveolar macrophages from critically ill patients with other diseases. In contrast, basal activation of NF-B in alveolar macrophages from normal volunteers appeared to be minimal (42) . This finding reinforces the earlier reports (54, 93) that IL-8 and TNF-␣ levels are increased in lung lavage samples from patients with ARDS.
Endothelial activation. Endothelial expression of molecules that mediate adhesion and signaling of leukocytes is the key to understanding the transcriptional mechanisms of acute lung injury (28, 43, 79, 110) . A significant advance is the concept that only the activated endothelium participates in the inflammatory response (150) . In lung injury, endothelial adhesion molecules have a role in recruiting inflammatory cells such as neutrophils and lymphocytes from the circulation to the site of inflammation. NF-B regulates the expression of several genes that encode adhesion molecules such as ICAM-1, vascular cell adhesion molecule-1, and E-selectin. Cytokine-induced cell surface expression of E-selectin, vascular cell adhesion molecule-1, and ICAM-1 and the secretion of IL-8 as well as of other chemokines are regulated at the transcriptional level in endothelial cells by the binding of NF-B to its putative site in the 5Ј-flanking sequences (8) . NF-B-dependent expression of these molecules is downregulated in endothelial cells by treatment with antioxidants (25) . This finding suggests a central role for NF-B in the activation of genes in endothelial cells, the products of which promote the adhesion and extravasation of leukocytes across the endothelial barrier.
MODULATION OF NF-B ACTIVATION IN LUNGS
The regulation of inflammation by cytokines involves an intricate balance of pro-and anti-inflammatory mediators. The principal anti-inflammatory cytokines released in lung tissue include IL-1RA, IL-4, IL-6, IL-10, IL-11, IL-13, and TGF-␤. The soluble cytokine receptors TNF receptor p55, TNF receptor p75, and IL-1 receptor type 2; the membrane-bound IL-1 receptor type 2; and the IL-18 binding protein also have antiinflammatory activities. However, only a few of these have been shown to involve in lung injury via interaction with NF-B.
Intrapulmonary deposition of IgG immune complexes in rats causes alveolar macrophage activation and results in neutrophil-dependent parenchymal cell injury as characterized by increased pulmonary vascular permeability and alveolar hemorrhage (61, 151) . Studies (32, (126) (127) (128) have identified IL-6, IL-10, IL-1RA, and IL-13 as endogenous regulators in this model of inflammatory lung injury. Lentsch et al. (70) showed that exogenously administered IL-4, IL-10, or IL-13 greatly attenuated the lung injury induced by IgG immune complexes and demonstrated that both IL-10 and IL-13 inhibited nuclear localization of NF-B in alveolar macrophages and lung tissues in a manner associated with preserved expression of IB-␣ protein.
These findings suggest that IL-10 and IL-13 reduce lung inflammation by preventing degradation of IB-␣, thus inhibiting the activation of NF-B.
Schottelius et al. (119) showed that IL-10 functions to block NF-B activity at two levels, through 1) suppression of IKK activity and 2) inhibition of NF-B DNA binding activity. To address the mechanism of action of IL-10, Wang et al. (149) tested the effects of IL-10 on different transcription factors including NF-B, NF-IL-6, activator protein (AP)-1, AP-2, glucocorticoid receptor, cAMP response element binding protein (CREB), Oct-1, and Sp1. They found that IL-10 selectively prevented NF-B activation, with the effect occurring rapidly and in a dose-dependent manner. Moreover, the effect was correlated with the cytokine synthesis inhibitory activity of IL-10. IL-10 inhibited chemokine expression (MIP-1␣ and MIP-2) by inducing both mRNA destabilization and NF-B inhibition (130) . However, IL-4, which also inhibited cytokine mRNA accumulation in monocytes, showed little inhibitory effect on LPS-induced NF-B activation (149) . Unlike IL-10, IL-4 enhanced mRNA degradation and failed to suppress cytokine gene transcription. These data point to distinct roles for IL-10 and IL-4 in inhibiting cytokine production by different mechanisms.
TGF-␤, a pleiotropic cytokine/growth factor, is believed to play a critical role in the modulation of inflammatory events. DiChiara et al. (33) demonstrated that exogenous TGF-␤1 inhibited the expression of the proinflammatory adhesion molecule E-selectin in vascular endothelium exposed to inflammatory stimuli. This inhibitory effect occurred at the level of transcription of the E-selectin gene and was dependent on the action of Smad proteins, a class of intracellular signaling proteins mediating the cellular effects of TGF-␤1 (33) . Furthermore, this work demonstrated that Smadmediated effects in endothelial cells resulted from a competitive interaction between Smad proteins activated by TGF-␤1 and NF-B activated by inflammatory stimuli (such as cytokines or bacterial LPS). This interaction is mediated by the transcriptional coactivator CREB-binding protein (CBP) (33) . Augmentation of the limited amount of CBP present in endothelial cells (via overexpression) or selective disruption of Smad-CBP interactions (via a dominant negative strategy) effectively antagonized the ability of TGF-␤1 to block proinflammatory E-selectin expression (33) . These data demonstrate a potentially important interaction between TGF␤-1-regulated Smad proteins and NF-B that is regulated by inflammatory stimuli in endothelial cells.
INTERACTIONS BETWEEN NF-B AND OTHER TRANSCRIPTION FACTORS
NF-B can differentially regulate the expression of many genes involved in inflammatory processes with different functions, in different cell types, and at different times. This diversity arises from a delicately balanced network of protein-protein interactions. NF-B activity is determined not only through its regulated nuclear localization signal but also by the cellular context. NF-B interacts with a large number of heterologous transcription factors, and these interactions can select for specific NF-B subunits and thereby lead to greater transcriptional selectivity. AP-1 is one such transcription factor involved in the control of many inflammatory mediators. AP-1 is com- (75) . NF-B p50/p65 heterodimers were bound to the B3 site and c-Jun was bound to the Ϫ103 AP-1 site of the TNF-␣ promoter after LPS stimulation. By transient transfection, NF-B p65 and p50 were shown to synergistically activate the TNF-␣ promoter. In contrast, such synergy was not observed between NF-B p65 or NF-B p50 and c-Jun or C/EBP-␤ even in the presence of the coactivator p300 (75) . This result suggests that adjacent B3 and AP-1 sites in the human TNF-␣ promoter contribute independently to the LPS-induced activation response. More work is needed to determine how AP-1 interacts with other transcriptional factors such as NF-B and thereby controls the inflammatory responses resulting in acute lung injury.
The C/EBP family of transcription factors, together with AP-1 and activating transcription factor/CREB, belong to a class of DNA binding proteins termed bZIP proteins (146) . These proteins are characterized by their leucine zipper structure and the adjacent DNA binding basic region, both located in the COOH-terminal portion of the proteins. Four members of the C/EBP family, C/EBP-␣, C/EBP-␤, C/EBP-␥, and C/EBP-␦ (24), form homodimers and heterodimers with each other and bind with a similar affinity to various C/EBP binding sites (24, 66) . Stein et al. (138) demonstrated a functional and physical association between NF-B and C/EBP. These associations are characterized by 1) inhibition of NF-B-induced expression of promoters containing NF-B binding sites by the expression of C/EBP family members and 2) positive synergistic action of NF-B family members with C/EBP family members on promoters containing C/EBP binding sites.
Evidence indicates that NF-B subunits act in concert with members of the C/EBP family of transcription factors in regulating gene expression mediated by the multimerized c-Fos serum response element (138) . Several functional NF-B subunits (p50, p65, and cRel) interacted with three different isoforms of C/EBP (␣, ␤, and ␦) (138) , indicating an interaction between these families and not merely a limited interaction between individual members. In another study (136) , it was shown that C/EBP repressed NF-B transactivation through B elements, whereas NF-B stimulated DNA binding and transactivation through C/EBP binding sites. The IL-8 promoter contains a region with binding sites for both NF-B and C/EBP in close proximity that is required for TNF-␣-and IL-1␤-mediated activation (136) . NF-B and C/EBP cooperatively bind this element and thereby induce the expression of IL-8 (136) . Thus C/EBP specifically modulates NF-B function and cooperatively stimulates the transcription of genes.
Binding elements for NF-B and CREB are present in the enhancer/promoter regions of the immunoregulatory cytokine genes IL-1␤ and TNF-␣ and have important functions in modulating transcription of these genes (9, 125, 145) . NF-B and CREB were activated in the lungs after endotoxemia or blood loss (16, 67, 131) ; however, precisely how these two transcription factors cooperate to control inflammatory gene transcription in acute lung injury remains unclear.
High-mobility group protein-1 (HMG-1) is a highly conserved protein with Ͼ95% amino acid identity between rodents and humans (80, 105) . HMG-1 was initially identified as a nonhistone nuclear protein that binds to the narrow minor groove of the AT sequencerich B form of DNA. HMG-1 has been implicated in the regulation of gene transcription and in stabilizing nucleosome formation (15, 52, 58, 80, 105) . A study (148) showed that HMG-1 is a key late mediator of endotoxin lethality. HMG-1 given intratracheally produced acute inflammatory injury in the lungs, with neutrophil accumulation, development of lung edema, and increased pulmonary production of IL-1␤, TNF-␣, and MIP-2 (1). In endotoxin-induced acute lung inflammation, administration of anti-HMG-1 antibody either before or after endotoxin challenge decreased the migration of neutrophils into the lungs and prevented pulmonary edema. These protective effects of the anti-HMG-1 antibody were specific because pulmonary levels of IL-1␤, TNF-␣, or MIP-2 were not decreased after therapy with the anti-HMG-1 antibody (1), thus pointing to a role for HMG-1 as a distal mediator of acute inflammatory lung injury.
The experiments of Brickman et al. (22) revealed the interaction between HMG-1 protein and members of the NF-B family. They showed that the Drosophila protein DSP1, a HMG-1/2-like protein, binds DNA cooperatively with NF-B, the p50 subunit of NF-B, and the Rel domain of Dorsal (22) . This cooperativity is also apparent with other DNA molecules bearing consensus Rel protein binding sites. Moreover, the cooperativity observed in these DNA binding assays is paralleled by interactions between protein pairs in the absence of DNA. It is apparent from the work thus far that further studies addressing the significance of interactions of HMG-1 with NF-B in the mechanism of acute lung injury will be important.
There is growing evidence that the regulation of gene expression is not mediated solely by the presence or absence of a particular set of transcription factors. The mechanisms regulating NF-B activation, NF-B by IB, and the interactions of NF-B with other transcription factors are complex. Additional studies that make functional sense of this complexity will not only enhance our understanding of the role played by transcription factors in mediating lung inflammation and acute lung injury but will also lead to novel therapies directed against lung inflammation.
SUMMARY
Transcriptional activities in which the NF-B family members play a central position are key to understanding the pathobiology of acute lung injury. Therefore, modification of transcription becomes a logical therapeutic target for acute lung injury. Activation of NF-B and other transcription factors represents a complex network of finely balanced protein-protein interactions. The balance of proinflammatory to anti-inflammatory cytokines is regulated by a highly intricate network of transcription factors. Under pathological conditions, anti-inflammatory mediators provide insufficient control over proinflammatory activities. Despite the complexities inherent in the human immune response, therapeutic intervention with specific inhibitors of transcription signaling may have significant benefits in lung injury. Future studies in this area are likely to lead to novel therapies for the wide range of NF-B-mediated inflammatory diseases including acute lung injury.
